Showing results (1061-1070 of 1,437) with videos related to

Sort By:
Pageof 144
Stem Cell Reports|March 11, 2015
The polycomb group protein L3MBTL1 represses a SMAD5-mediated hematopoietic transcriptional program in human pluripotent stem cellsFabiana Perna, Ly P Vu, Maria Themeli, et al.
Cancer Immunology, Immunotherapy : CII|October 25, 2011
Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remissionChristina S Chu, Jean Boyer, Daniel S Schullery, et al.
Blood|June 29, 2006
JAK2T875N is a novel activating mutation that results in myeloproliferative disease with features of megakaryoblastic leukemia in a murine bone marrow transplantation modelThomas Mercher, Gerlinde Wernig, Sandra A Moore, et al.
Blood|December 17, 2008
High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patientsJeffrey W Tyner, Heidi Erickson, Michael W N Deininger, et al.
The Journal of Molecular Diagnostics : JMD|July 15, 2014
Detection of mutations in myeloid malignancies through paired-sample analysis of microdroplet-PCR deep sequencing dataDonavan T Cheng, Janice Cheng, Talia N Mitchell, et al.
Cancer Cell|February 15, 2011
JAK2V617F-mediated phosphorylation of PRMT5 downregulates its methyltransferase activity and promotes myeloproliferationFan Liu, Xinyang Zhao, Fabiana Perna, et al.
Blood|February 22, 2007
CD28-mediated regulation of multiple myeloma cell proliferation and survivalNizar J Bahlis, Anne M King, Despina Kolonias, et al.
American Journal of Hematology|May 31, 2013
Transcriptomic and phospho-proteomic analyzes of erythroblasts expanded in vitro from normal donors and from patients with polycythemia veraTodd Hricik, Giulia Federici, Ann Zeuner, et al.
Blood|January 29, 2014
Improved targeting of JAK2 leads to increased therapeutic efficacy in myeloproliferative neoplasmsNeha Bhagwat, Priya Koppikar, Matthew Keller, et al.
Molecular and Cellular Biology|October 29, 2004
Carbonic anhydrase III is not required in the mouse for normal growth, development, and life spanGeumsoo Kim, Tae-Hoon Lee, Petra Wetzel, et al.
Pageof 144